CN111484964A - High-yield 9-OHAD mycobacterium and construction method thereof - Google Patents
High-yield 9-OHAD mycobacterium and construction method thereof Download PDFInfo
- Publication number
- CN111484964A CN111484964A CN202010178401.1A CN202010178401A CN111484964A CN 111484964 A CN111484964 A CN 111484964A CN 202010178401 A CN202010178401 A CN 202010178401A CN 111484964 A CN111484964 A CN 111484964A
- Authority
- CN
- China
- Prior art keywords
- artificial sequence
- plasmid
- gene
- deletion
- ohad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010276 construction Methods 0.000 title claims abstract description 17
- 241000186359 Mycobacterium Species 0.000 title claims abstract description 15
- 229930182558 Sterol Natural products 0.000 claims abstract description 26
- 150000003432 sterols Chemical class 0.000 claims abstract description 26
- 235000003702 sterols Nutrition 0.000 claims abstract description 26
- 230000014509 gene expression Effects 0.000 claims abstract description 24
- 238000004458 analytical method Methods 0.000 claims abstract description 16
- 238000011529 RT qPCR Methods 0.000 claims abstract description 13
- 238000001514 detection method Methods 0.000 claims abstract description 11
- 230000004060 metabolic process Effects 0.000 claims abstract description 7
- 238000003762 quantitative reverse transcription PCR Methods 0.000 claims abstract description 7
- 239000013604 expression vector Substances 0.000 claims abstract description 5
- 238000002123 RNA extraction Methods 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims abstract description 4
- 238000011002 quantification Methods 0.000 claims abstract description 4
- 108020004414 DNA Proteins 0.000 claims description 60
- 108090000623 proteins and genes Proteins 0.000 claims description 50
- 239000013612 plasmid Substances 0.000 claims description 49
- 239000001963 growth medium Substances 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 238000012217 deletion Methods 0.000 claims description 13
- 230000037430 deletion Effects 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 101100066211 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) fadA5 gene Proteins 0.000 claims description 9
- 101150052277 cyp125 gene Proteins 0.000 claims description 9
- 239000012154 double-distilled water Substances 0.000 claims description 9
- 239000000523 sample Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 230000009466 transformation Effects 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 239000002299 complementary DNA Substances 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 238000010839 reverse transcription Methods 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000004520 electroporation Methods 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 4
- 238000011218 seed culture Methods 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 108091093088 Amplicon Proteins 0.000 claims description 3
- 108091034117 Oligonucleotide Proteins 0.000 claims description 3
- 239000013614 RNA sample Substances 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 238000002247 constant time method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- -1 fade 19 Proteins 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 101150083365 hmp gene Proteins 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 101150100531 kshB gene Proteins 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000012795 verification Methods 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims 4
- 238000001816 cooling Methods 0.000 claims 2
- 238000012224 gene deletion Methods 0.000 claims 2
- WBVHXPUFAVGIAT-UHFFFAOYSA-N [C].OCC(O)CO Chemical compound [C].OCC(O)CO WBVHXPUFAVGIAT-UHFFFAOYSA-N 0.000 claims 1
- 238000000246 agarose gel electrophoresis Methods 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 108010023417 cholesterol dehydrogenase Proteins 0.000 description 17
- 108010085346 steroid delta-isomerase Proteins 0.000 description 17
- 108010089254 Cholesterol oxidase Proteins 0.000 description 16
- 230000004044 response Effects 0.000 description 13
- 150000003431 steroids Chemical class 0.000 description 13
- 230000015556 catabolic process Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 238000006731 degradation reaction Methods 0.000 description 10
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 9
- 229940068065 phytosterols Drugs 0.000 description 9
- 238000009825 accumulation Methods 0.000 description 8
- 230000002103 transcriptional effect Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 101150082341 fadD19 gene Proteins 0.000 description 5
- 230000002018 overexpression Effects 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- 108010070743 3(or 17)-beta-hydroxysteroid dehydrogenase Proteins 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- 101150076489 B gene Proteins 0.000 description 2
- 102100034067 Dehydrogenase/reductase SDR family member 11 Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010564 aerobic fermentation Methods 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 2
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 101150004992 fadA gene Proteins 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000019837 monoammonium phosphate Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 125000002328 sterol group Chemical group 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 1
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 1
- 101710116689 3-oxosteroid 1-dehydrogenase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108020004513 Bacterial RNA Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 101150071111 FADD gene Proteins 0.000 description 1
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
- 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
- 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
- 101710106940 Iron oxidase Proteins 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 241000187488 Mycobacterium sp. Species 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 238000003197 gene knockdown Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 101150033284 ksh gene Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 102000045222 parkin Human genes 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical group O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/99—Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
- C12Y103/99004—3-Oxosteroid 1-dehydrogenase (1.3.99.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/99—Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
- C12Y103/99005—3-Oxo-5alpha-steroid 4-dehydrogenase (acceptor) (1.3.99.5), i.e. steroid-5alpha-reductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
- C12Y114/13142—3-Ketosteroid 9alpha-monooxygenase (1.14.13.142)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y208/00—Transferases transferring sulfur-containing groups (2.8)
- C12Y208/02—Sulfotransferases (2.8.2)
- C12Y208/02017—Chondroitin 6-sulfotransferase (2.8.2.17)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a high-yield 9-OHAD mycobacterium and a construction method thereof, which are characterized by comprising the following steps of (I) RNA extraction and RT-qPCR analysis, (II) knockout of kstd strain construction, (III) construction of sterol metabolism related gene expression vector, (IV) mycobacterium electrotransformation, and (V) sample extraction, detection and quantification.
Description
The technical field is as follows:
the invention relates to a mycobacterium with high 9-OHAD yield and a construction method thereof, belonging to the field of biological genetic engineering.
Background art:
steroids are a natural chemical component widely existing in nature, and with the appearance of more and more diseases, steroid hormone drugs have gradually developed into an important class in the field of medicine. Actinomycetes exhibit natural advantages over other species in their utilization and metabolism of xenobiotics, and in some cases sterols can also serve as carbon and energy sources for microorganisms. The mycobacterium may use natural sterols or some other steroid as the sole carbon and energy source. Disruption of the mycobacterial catabolic pathway results in the excessive accumulation of some important intermediates, such as AD and 9-OHAD, which can be used as precursors for the production of steroid hormone drugs.
The study shows that the complete degradation of a steroid molecule into a small molecule energy substance comprises four steps, namely the uptake of the steroid molecule, the degradation of the steroid nucleus, the oxidation of the side chain group, the biological contact of the steroid substance in the uptake environment of actinomycetes, the efficiency of the hydrophobic sterol molecule into the phospholipid layer by producing and secreting specific surfactants, the cholesterol oxidase or dehydrogenase present outside the cell is one of the positive factors for the transport of cholesterol, the branched degradation of the sterol is similar to that of fatty acid β -oxidation, the cholesterol retention is based on 1 unit β -cholesterol, the cholesterol oxidase or dehydrogenase is induced by the degradation of the steroid coenzyme, the cholesterol dehydrogenase is induced by the cholesterol oxidase or dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase, the cholesterol oxidase, the cholesterol dehydrogenase.
Disclosure of Invention
In order to obtain high yield of 9-OHAD, the present invention focuses on the molecular modification of mycobacteria mainly on the ring-opening of the steroid nucleus, such as overexpression of 3-steroid-9 a-hydroxylase (KSH) and knock-out of 3-steroid-D1-dehydrogenase (KstD), with little uptake and side chain degradation of phytosterols, both of which are equally important for high yield of 9-OHAD, and both of which are required for rapid uptake of phytosterols and high yield of 9-OHAD.Studies show that the complete degradation of a steroid molecule into small molecular energy substances takes place in four steps, uptake of sterol molecules, ring-opening of the steroid nucleus, degradation of the ring-opened steroid nucleus, oxidation of side chain groups, determination of key genes affecting 9-OHAD production by quantitative fluorescence PCR, knock-out of genes accumulating 9-OHAD, and simultaneous overexpression of some of genes 3 β -KDs, 5 α -std, side chain degradation and ring-opened nuclear degradation of the three modules, and results show that the original yield of mycobacteria is increased by 9-OHAD 366.6.366.
The invention provides a method for constructing a mycobacterium with high 9-OHAD yield, which comprises the following steps: RNA extraction and RT-qPCR analysis
RNA was isolated from mycobacterial sterol transformation media using RNAprep pure cell/bacteria kit (TIANGEN.) total RNA from different samples was concentrated in 30 μ L RNase free water according to kit instructions.
Reverse transcription of 1. mu.g total RNA using the FastQuant cDNA kit (TIANGEN). according to the kit instructions, total RNA samples were pretreated with Dnase I2. mu. L5 × g DNA buffer, 1. mu.g total RNA, adjusted to 10. mu. L with ddH2O, incubated for 3min at 42 ℃ and then immediately cooled ice.A reverse transcription reaction mixture was then prepared 2. mu. L10 × Fast RT buffer, 1. mu. L RTEnzymaMix, 2. mu. L FQ-RT primer MIX, 1. mu.g total RNA, adjusted to 20. mu. L with ddH2O, incubated for 15min at 42 ℃ and then incubated for 3min at 95 ℃ and then immediately cooled on ice-20 ℃ and the mixture was diluted 10-fold prior to NanoDrop quantitation.
Gene-specific qRT-PCR primers were designed and qRT-PCR was performed in cfx96(BioRad) using the SuperReal PreMix Plus kit (SYBRGreen) (Tiangen). 2. mu. L of the above cDNA samples were mixed with 0.6. mu. L + 0.6. mu. L specific oligonucleotide, 10. mu. L2 × SuperReal PreMix Plus and 6.8. mu. L RNase-free ddH2O was thoroughly mixed in 20. mu. L reaction mixture RT-qPCR reactions were performed for 15min of pre-denaturation at 95 ℃ for 10 sec for 40 cycles, 20 sec at 60 ℃, 20 sec at 72 ℃, 20 sec, followed by a melting curve phase at 55 ℃ to 95 ℃Groups are strains that grow on a phytosterol carbon source. Each sample was analyzed in triplicate. Relative expression levels were calculated using the 2- Δ Δ CT method with the 16SrRNA gene amplicon as an internal control.
Construction of (two) knock-out kstd Strain
To delete kstd1 or kstd3, two fragments of upstream sequences 1112bp or 1361bp were first cloned by primers kstd1-up-f/kstd3-up-r or kstd 1-down-respectively, and downstream sequences 1057bp or 1293 bp. tdks 3-down/-r. the fragments were then ligated to 2175bp or 2656 by XbaI enzyme, then 2175bp or 2656bp fragments were digested with HindIII/NotI and then cloned into plasmid p2NI L. finally, a selection marker cassette digested with PacI from pGoal19 was inserted into the PacI site of p2NI L to generate homologous recombinant pdel-tdks 1 or pdel-kstd after alkali treatment, as described by gouhan and parkh, after successful transfer of the gene from tdtd strain 54 bp to tdtd 3978 bp or tdks 73 bp, or after deletion of the original recombinant pdel-tdks 3626 gene by electroporation with primers kstd 3978-9 or 99 bp, finally verified by PCR with primers 16820-20. the deletion of the original recombinant plasmid.
(III) construction of sterol metabolism-related Gene expression vector
The gene 3 β -Hsd was cloned from the genome of MS136 using Hsd-pf & pr, BamHI-HindIII and ligated into plasmid pMV261 at the BamHI-HindIII plasmid pMV261-Hsd was introduced into MS136 to obtain MS136 and MS136-H respectively, 5 α -reductase-pf & pr, cyp125-pf & pr, fade 19-pf & pr, fadA5-pf & pr, kshA-pf & pr and kshB-pf & pr. were used to clone the gene 5 α -4std, cyp125, fade 19, fadA5, hA and kshB from MS136 the genome using 5 α -redase-pf & pr, cys 6319, plasmid XbXgV 261-dli + plasmid XgHa + XgSk-hrsg & gt, plasmid XgHa + XgHa-hA + XgHa-hA & gH & pr..
(IV) Mycobacterium electrotransformation
And (2) treating the electric rotating cup (2mm), namely spraying 75% alcohol on the electric rotating cup, drying the electric rotating cup under ultraviolet rays on a clean bench, putting the electric rotating cup into an ice box for ice bath for 10min, taking a branched bacillus sensitive state tube, putting the branched bacillus sensitive state tube on the ice box ice, standing the electric rotating cup on the ice for 10min, adsorbing the competence added with the plasmid into the electric rotating cup, setting the parameter voltage of an electric rotating instrument to be 1800V, putting the electric rotating cup into an electric rotating instrument tank, performing electric rotation for 2 times, performing electric rotation, then performing ice bath for 3min, adding a seed culture medium of 800u L into the clean bench, centrifuging for 30min, recovering the electric rotating cup in a shaking table for 2-3 h.4000rpm for 5min, discarding supernatant, reserving about 100u L, resuspending the cells, sucking the cells by a liquid transfer gun onto a solid culture medium plate containing corresponding antibiotics, coating the solid culture medium plate uniformly until the cells are dry, observing the growth after about 5-7 days, and selecting bacteria for verification.
(V) sample extraction, detection and quantification
And (3) treating a product, namely putting 500u L of fermentation liquor into a centrifuge tube, centrifuging for 15min at 4000rpm, sucking supernatant liquid by using an injector, filtering the supernatant liquid into a clean centrifuge tube through a 0.22um water system membrane for later use, sucking 10u L of filtrate, adding the filtrate into 990u L of diluent, fully mixing the filtrate uniformly for subsequent analysis and detection, and storing the rest filtrate at-20 ℃.
And (3) detecting a product 9-OHAD, namely the 9-OHAD has a characteristic absorption peak under the ultraviolet wavelength of 240nm, and a substrate phytosterol has no characteristic absorption, so that the product is quantitatively analyzed by adopting an HP L C method standard curve, wherein the chromatographic conditions comprise that a chromatographic column is C18(250mm × 4.6.6 mm), the detection wavelength is 240nm, the column temperature is 50 ℃, the flow rate is 1.0m L/min, and mobile phases comprise ethanol, water, glacial acetic acid (520:480:0.1), a diluent comprises acetonitrile, water (50:50) and the sample injection amount is 20u L.
The invention has the beneficial effects that:
the invention firstly provides a method for modularly transforming mycobacteria to construct a high-yield 9-OHAD strain, and identifies the relationship between a plurality of genes and 9-OHAD accumulation, and the method improves the yield of 9-OHAD by over-expressing 3 β -HSD, 5 α -redutase and KSH genes in mycobacteria and simultaneously knocking off the KSTD gene, thereby providing a theoretical basis for future industrial production.
Description of the drawings:
FIG. 1 is a schematic illustration of the metabolism of phytosterols by mycobacteria.
FIG. 2 is a gene transcription analysis and engineering of Module A (a) transcriptional expression levels of genes 3 β -HSD and 5 α -reductase in the sterol uptake module (Module-A) in response to phytosterols (b) ligation of target genes (3 β -HSD or 5 α -reductase) into the pMV261 plasmid to overexpress a single gene to form two recombinant plasmids, (c) 9-OHAD was produced after overexpression of each gene using 13 g/L phytosterols as substrate and 9-OHAD production was detected 84 hours after inoculation.the control group transferred MS136 with blank pMV261 plasmid.
FIG. 3 is the transcriptional analysis and engineering of the Module B gene. (a) Transcriptional expression levels of the genes cyp125, fadD19, fadA5 and hsd4A in the side chain degradation module (module-B) in response to phytosterols. (b) Each target gene (cyp125, fadD19, or fadA5) was ligated into the pMV261 plasmid to form three recombinant plasmids. Only individual genes are overexpressed. (c) Production of 9-OHAD overexpressing each gene. Control MS136 was transformed with the blank pMV261 plasmid. The values in each curve are expressed as mean ± standard deviation (error bars) from three independent determinations.
FIG. 4 is a graph of gene transcription analysis and engineering of module-C, (a) the level of transcription expression of gene KSH in sterol nuclear open cycle module (module-C) in response to phytosterol, (b) the level of transcription expression of gene KStD in sterol nuclear open cycle module (module-C) in response to phytosterol, (C) ligation of target gene (KSH) into pMV261 plasmid to form a recombinant plasmid, (d) production of 9-OHAD overexpressing KSH gene control MS136 transferred into blank pMV261 plasmid, the value in each curve is expressed as the mean. + -. standard deviation (error bars) from three independent determinations, (e) phenotypic analysis of Mycobacterium 136 recombinant cells MS136 in medium with 10 g/L glycerol, the growth curve in each curve is observed in medium with 10 g/L glycerol, the value in each curve is spectroscopically determined by OD600 values of TDOD nm (f) the mean value in real-time production of 9-OHAD in 13 g/L phytosterol aerobic fermentation process, the value of Mycobacterium is expressed as the mean. + -. standard deviation of. + -. MS 136. 20 g/delks19 M.54. Del MS 136. 19. the error bars 363. 36136-Del MS 136.
FIG. 5 is a graph of construction of recombinant strain Mycobacterium sp.MS136-delkstd1+ H +4s + AB for enhanced 9-OHAD production (a) construction of recombinant plasmids.A selected gene 3 β -HSD (in module-A), 5 α -reductase (in module-A) and KSH (in module-C) was ligated into pMV261 plasmid: (b) time curves for 9-OHAD production by each recombinant strain in aerobic fermentation.the values in each curve are expressed as mean. + -. standard deviation from three independent determinations (error bars). MS136-pMV 261: MS136 strain with pMV261 plasmid; MS136-delkstd1-pMV 261: recombinant MS136 strain which knockouts KstD1 in chromosome and together with pMV 261. MS136-delkstd1+ H +4s + MS136 strain 136, and KSD 6746 strain which knockouts in chromosome 3-HSD, KSAB 261, KS5-dHA, and KSV 6778 in chromosome 6747, and KSV 6747-plasmid knockouts.
The specific implementation mode is as follows:
example 1
1 Material
1.1 strains, plasmids and media
All plasmids and strain information referred to in this example are detailed in Table 1 plasmids pMV261, p2NI L and pGOA L19 were purchased from Biosci.
L B liquid culture medium containing peptone 10 g/L, yeast extract 5 g/L10 g/L, pH 7.5, sterilized at 121 deg.C for 15min, L B solid culture medium containing peptone 10 g/L, yeast extract 5 g/L10 g/L, agar powder 15 g/L, pH 7.5, sterilized at 121 deg.C for 15 min.
The proportion of the trace elements is 10 g/L of magnesium sulfate, 0.5 g/L of ferrous sulfate, 0.2 g/L0 of zinc sulfate and pH 3-3.5, the seed culture medium comprises 1.5 g/L1 of ammonium dihydrogen phosphate, 10 g/L2 of glycerol, 10 g/L3 of yeast powder, 0.5 g/L4 of sodium dihydrogen phosphate, 0.5 g/L5 of disodium hydrogen phosphate, 802.5 g/L of tween, 10m L of trace elements and pH 7.0-7.3, the slant culture medium comprises 1.5 g/L of ammonium dihydrogen phosphate, 10 g/L of glycerol, 10 g/L of yeast powder, 0.5 g/L of sodium dihydrogen phosphate, 0.5 g/L of disodium hydrogen phosphate, 10m L of trace elements and pH 7.0-7.3.
The transformation medium comprises 0.8 g/L g of sodium dihydrogen phosphate, 2.52 g/L g of disodium hydrogen phosphate, 1.8 g/L g of ammonium sulfate, 800.2 g/L g of tween, 0.3 g/L g of urea, 13.2 g/L g of phytosterol-70 g/L g of cyclodextrin, 10m of trace elements L, 5 g/L g of glycerol and 7.0-7.3 of pH.
TABLE 1 strains and plasmids involved in the experiments
1.2 reagent and apparatus restriction enzymes BamHI, HindIII, EcoRI, NotI and PacI from Fermentas; a bacterial RNA extraction kit, a reverse transcription cDNA synthesis kit, a Superreal Premix Plus kit, a plasmid miniextraction kit, a common DNA product purification kit and an agarose gel DNA recovery kit are purchased from Tiangen corporation; 9-OHAD was purchased from Shanghai Boton Biochemical industries, Inc. The apparatus used was: high performance liquid chromatography (Waters), electrotransformer (Ependorf), Real-time PCR (BioRad), NanoDrop (NanoDrop 2000, Thermo).
1.3 primers used for PCR are shown in Table 2.
TABLE 2 primer sequences
2 method
2.1 Gene sequence analysis
Gene sequencing was done with the help of Novogene Bioinformatics technology.A comparative analysis of nucleotide and amino acid sequences was performed by the B L AST program of NCBI (National Center for Biotechnology Information Server, http:// blast.ncbi.nlm.nih.gov.) multiple sequence alignment was performed by DANMAN 6.0 conserved domains in proteins were also searched on the NCBI website (http:// www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi.) A phylogenetic tree was constructed using the MEGA 5.1 software package with ClustalW and the adjacency algorithm.
The construction method of the high-yield 9-OHAD mycobacterium provided by the embodiment specifically comprises the following steps:
2.2 RNA extraction and RT-qPCR analysis
RNA was isolated from mycobacterial sterol transformation media using RNAprep pure cell/bacteria kit (TIANGEN.) total RNA from different samples was concentrated in 30 μ L RNase free water according to kit instructions.
Total RNA samples were pretreated with Dnase I, 2 μ L5 × g DNA buffer, 1 μ g total RNA, adjusted to 10 μ L with ddH2O, incubated at 42 ℃ for 3min, then immediately cooled ice according to kit instructions, then reverse transcription reaction mixtures were prepared 2 μ L10 × Fast RT buffer, 1 μ L RTEnzymaMix, 2 μ L FQ-RT primer MIX, 1 μ g total RNA, adjusted to 20 μ L with ddH2O, incubated at 42 ℃ for 15min, then incubated at 95 ℃ for 3min, then immediately cooled on ice-20 ℃ for storage for the next experiment-the mixtures were diluted 10 fold before NanoDrop quantitation.
Gene-specific qRT-PCR primers (Table 2) were designed and qRT-PCR was performed in cfx96(BioRad) using the SuperReal PreMix Plus kit (SYBRGreen) (Tiangen). 2. mu. L of the above cDNA samples were mixed with 0.6. mu. L + 0.6. mu. L specific oligonucleotides, 10. mu. L2 × SuperReal PreMix Plus and 6.8. mu. L RNase-free ddH2O was thoroughly mixed in 20. mu. L reaction mixture RT-qPCR was performed for 15min of pre-denaturation at 95 ℃ for 10 sec for 40 cycles, at 60 ℃ for 20 sec, at 72 ℃ for 20 sec, followed by a melting curve phase at 55 ℃ to 95 ℃The strains grown in the source, the test group were strains grown in a phytosterol carbon source. Each sample was analyzed in triplicate. Relative expression levels were calculated using the 2- Δ Δ CT method with the 16SrRNA gene amplicon as an internal control.
2.3 construction of knock-out kstd Strain
To delete kstd1 or kstd3, first two fragments of upstream sequences 1112bp or 1361bp, respectively, were cloned by primers kstd1-up-f/kstd3-up-r or kstd 1-down-then fragments were ligated to 2175bp or 2656 by XbaI enzyme, then fragments of upstream sequences 1057bp or 1293 bp. kstd 3-down/-r, respectively, subsequently the fragments of upstream sequences 1055 bp or 2656bp were digested with HindIII/NotI, then cloned into plasmid p2NI L. finally, the PacI site of p2NI L was inserted using the PacI single digested selection marker cassette from pGoal19 to generate homologous recombinant plasmids pdel-td 1 or pdel-tdks 3. alkali treated, after having been treated with parkin, the pckscd 19, after having been successfully deleted from the pckstd 3978 to 99 bp, or after having been confirmed by electroporation using primers kstd 3978-99 bp, or deletion of the original gene by PCR with primers kstd 99 bp, finally plasmid 3-99 bp, after having been deleted by electroporation with the pckstd 99, the plasmid 3-20 bp, the plasmid 3-tdksd strain, or after having been successfully deleted by PCR.
2.4 construction of sterol metabolism-related Gene expression vector
The gene 3 β -Hsd was cloned from the genome of MS136 using Hsd-pf & pr, BamHI-HindIII and ligated into plasmid pMV261 at the BamHI-HindIII plasmid pMV261-Hsd was introduced into MS136 to obtain MS136 and MS136-H respectively, 5 α -reductase-pf & pr, cyp125-pf & pr, fade 19-pf & pr, fadA5-pf & pr, kshA-pf & pr and kshB-pf & pr. were used to clone the gene 5 α -4std, cyp125, fade 19, fadA5, hA and kshB from MS136 the genome using 5 α -redase-pf & pr, cys 6319, plasmid XbXgV 261-dli + plasmid XgHa + XgSk-hrsg & gt, plasmid XgHa + XgHa-hA + XgHa-hA & gH & pr..
2.5 Mycobacterium electrotransformation
And (2) treating the electric rotating cup (2mm), namely spraying 75% alcohol on the electric rotating cup, drying the electric rotating cup under ultraviolet rays on a clean bench, putting the electric rotating cup into an ice box for ice bath for 10min, taking a branched bacillus sensitive state tube, putting the branched bacillus sensitive state tube on the ice box ice, standing the electric rotating cup on the ice for 10min, adsorbing the competence added with the plasmid into the electric rotating cup, setting the parameter voltage of an electric rotating instrument to be 1800V, putting the electric rotating cup into an electric rotating instrument tank, performing electric rotation for 2 times, performing electric rotation, then performing ice bath for 3min, adding a seed culture medium of 800u L into the clean bench, centrifuging for 30min, recovering the electric rotating cup in a shaking table for 2-3 h.4000rpm for 5min, discarding supernatant, reserving about 100u L, resuspending the cells, sucking the cells by a liquid transfer gun onto a solid culture medium plate containing corresponding antibiotics, coating the solid culture medium plate uniformly until the cells are dry, observing the growth after about 5-7 days, and selecting bacteria for verification.
2.6 extraction, detection and quantification of samples
And (3) treating a product, namely putting 500u L of fermentation liquor into a centrifuge tube, centrifuging for 15min at 4000rpm, sucking supernatant liquid by using an injector, filtering the supernatant liquid into a clean centrifuge tube through a 0.22um water system membrane for later use, sucking 10u L of filtrate, adding the filtrate into 990u L of diluent, fully mixing the filtrate uniformly for subsequent analysis and detection, and storing the rest filtrate at-20 ℃.
And (3) detecting a product 9-OHAD, namely the 9-OHAD has a characteristic absorption peak under the ultraviolet wavelength of 240nm, and a substrate phytosterol has no characteristic absorption, so that the product is quantitatively analyzed by adopting an HP L C method standard curve, wherein the chromatographic conditions comprise that a chromatographic column is C18(250mm × 4.6.6 mm), the detection wavelength is 240nm, the column temperature is 50 ℃, the flow rate is 1.0m L/min, and mobile phases comprise ethanol, water, glacial acetic acid (520:480:0.1), a diluent comprises acetonitrile, water (50:50) and the sample injection amount is 20u L.
Example 2 transcriptional analysis and engineering of Module genes
1. Transcriptional analysis and engineering of Module A genes
In bacteria, the oxidation of the 3' -hydroxyl group catalyzes the isodehydrogenase of cholesterol 5-en-3-one to cholesterol 4-en-3-one from hydroxysteroids (Hsd). A putative 3-oxo-5 α -steroid-4-dehydrogenase protein coding sequence, designated 5 α -reductase, was found to encode a putative protein of 263 amino acids.
In order to explore the potential functions of 3 β -hsd and 5 α -reductases in sterol bioconversion processes, transformation media such as sterol were transferred as carbon sources after activation of the strains with glycerol as a carbon source phytosterols were used as a key period for carbon source growth after 0-120 hours of inoculation of the transformation media.the expression response of both genes was systematically analyzed by quantitative PCR in FIG. 2a, the exploration of 3 β -hsd and 5 α -reductases detected in this study generally showed induction profiles.
Two genes, 3 β -hsd and 5 α -reductase, were selected to construct expression vectors based on the gene expression reaction of bacterial strains phytosterol as a carbon source to enhance mycobacteria MS136 sterol uptake capacity when the genes for 3 β -hsd and 5 α -reductase were overexpressed, 9-OHAD production increased, control was the strain of MS136 strain with the pMV261 plasmid (fig. 2c), MS136-H and MS 136-S9-OHAD production increased 8.5% and 9.1%, respectively.
2-Modular B Gene transcriptional analysis and engineering
The deletion of cytochrome P450 cyp125 gene will lead to the accumulation of 4-cholest-4-en-3-one, which cannot continue to convert cholesterol.fadD 19 encodes an acyl-CoA synthetase.fadA is an enzyme that catalyzes the thiolation of the linear fatty acid CoA (or acetoacetyl-CoA). 17 β -hydroxysteroid dehydrogenase also plays a role in the oxidation of the sterol side chain β.Hydroxysteroid dehydrogenase (17 β -hydroxysteroid dehydrogenase) protein is found to be named hsd 4A.
Side chain oxidation of sterols involves a variety of enzymatic catalysis. We selected four genes, cyp125, fadD19, fadA5 and hsd4A, for sterol expression response testing. Phytosterols were used as the key carbon source for growth after 0-120 hours of inoculation of the transformation medium. The expression responses of these four genes were systematically analyzed by quantitative PCR. In FIG. 3a, four genes, cyp125, fadD19, fadA5 and hsd4A, show expression responses to sterols. Cyp125, fadA5 and hsd4A showed expression responses occurring at 72 hours. FadD19 showed two expression responses at 72 and 120 hours.
Based on 1 unit β -sitosterol, when it degrades to intermediate AD or 9-OHAD, it undergoes a dozen steps of enzymatic reactions that can produce 3 units of propionyl-coa and 1 unit of acetyl-coa, to enhance the ability of the strain to degrade sterol side chains, we chose three genes (cyp125, fadD19 and fadA5) overexpression treatment to up-regulate sterol metabolism, unfortunately, we did not get the pressure to successfully express fadA 5.
Transcriptional analysis and engineering of 3-module C genes
Module C mainly comprises 3-ketosteroid-1-dehydrogenase (KstD) and 3-ketosteroid-9-hydroxylase (KSH), forming the structure of 9-hydroxy-1, 4-dien steroid (9-OHADD).
In screening industrial steroid microorganisms, KstD and KSH are key enzymes for the production of important precursors of sterols, such as AD and 9-OHAD. In order to search potential functions in the KSH and KstD sterol biotransformation process, glycerol is used as a carbon source to activate the strain, sterol is used as a carbon source of a culture medium, and the key period of phytosterol in the culture medium can be transformed within 0-120h after inoculation. Growth of carbon source, and systematic analysis of gene expression of two reactions by quantitative PCR method. In fig. 4c, KstD1 and KstD3 showed expression responses at 96 hours, while KstD2 showed no expression responses. In FIG. 4b, the expression response of KSHA1 and KSHB appeared at 72 hours, the expression peak appeared at 120 hours, and the expression level of KSHA2 was almost unchanged.
In 9 α -hydroxylation of steroids, KSH activity consists of two parts, terminal oxygenase (KSHA of KSH) and iron oxidase (KSHB of KSH). multiple KSHA activities were observed in some strains using strong sterols, indicating an important role for KSHA in 9 α -hydroxylation.
Because of the transcriptional silencing of KstD2, knock-down of KstD homologs was constructed based on KstD1 and KstD3 in this fraction for accumulation of 9-OHAD. In FIG. 4e, it can be seen that the MS136-delkstd deletion strain showed similar growth rate on glycerol as its parent strain for the first 48 hours. However, from 60 hours on, the growth rate of MS136-delkstd was significantly faster than MS 136. The strains MS136-delkstd1 and MS136-delkstd1+ 3 were not viable in phytosterols, whereas MS136 and MS136-delkstd2 were able to grow normally. In FIG. 4f, the 9-OHAD yield started to increase significantly after 72 hours, the 9-OHAD yields of MS136 and MS136-delkstd3 started to decrease rapidly, and the yields of MS136-delkstd1 and MS136-delkstd1+ 3 continued to increase. The yield reached the highest at 120 h. Knock-out of KstD1 had a significant effect on 9-OHAD accumulation. KstD3 had no significant effect on 9-OHAD accumulation.
Modular construction of 49-OHAD high-yield recombinant strains
Based on the molecular modification results of each module, we selected 3 genes (3 β -HSD, 5 α -reductase and KSH) with significantly increased 9-OHAD accumulation, constructed a common overexpression vector of the three genes and knocked-out kstD1 to construct a high-yield 9-OHAD strain, namely MS136-delkstd1+ H + S + AB fermentation results (FIG. 5b), and showed that the accumulation of MS136-delkstd1+ H + S + AB9-OHAD is slightly smaller than MS136-delkstd1 before 60 hours, but showed similar growth rate, and after 60 hours, the yield of MS136-delkstd1+ H + S + AB was significantly increased, 108 hours was highest, 6.6 g/L, and the yield of MS136-delkstd-pMV261 was also highest at 108 hours, 5.8 g/L.
Sequence listing
<110> Qingdao ocean technology research institute of Tianjin university
<120> a high 9-OHAD producing mycobacterium and its construction method
<160>55
<170>SIPOSequenceListing 1.0
<210>1
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>1
cgggatccat gggtgacgca tctttgacca c 31
<210>2
<211>32
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
cccaagcttt cagcgggcga ccgctgccgc ag 32
<210>3
<211>29
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
cgggatccat gcattggtac accggcaac 29
<210>4
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
cccaagcttt cacaggacgt aggggatgag a 31
<210>5
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
cgggatccat gggctgcccc aacatcccca 30
<210>6
<211>34
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>6
cccaagcttt cagtggctga ccgggcactt accg 34
<210>7
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>7
cgggatccat ggctctgaat attgctgatc t 31
<210>8
<211>32
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>8
cccaagcttc tatttggctc ccacgtgatt gg 32
<210>9
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>9
cgggatccat gcctgaggct tacatcgtcg 30
<210>10
<211>32
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>10
cccaagcttt cagaggcgct cgatgatcgt ga 32
<210>11
<211>27
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>11
cgggatccat gactaccgag acagccg 27
<210>12
<211>26
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>12
cccaagcttt cagctcggct gaccgg 26
<210>13
<211>42
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>13
cccaagcttg gaggaaatat acatgacgga ggaaccgctc gg 42
<210>14
<211>26
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>14
cggaattcct attcgtaggt gacttc26
<210>15
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>15
cgggatccat gggtgacgca tctttgacca c 31
<210>16
<211>27
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>16
gactagttca gcgggcgacc gctgccg 27
<210>17
<211>40
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>17
gctctagagg aggaacatac gatgcattgg tacaccggca 40
<210>18
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>18
ccgctcgagt cacaggacgt aggggatgag a 31
<210>19
<211>41
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>19
ccgctcgagg gaggaaacat acatgactac cgagacagcc g 41
<210>20
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>20
cccaagcttg gcatttccac tcccttattc g 31
<210>21
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>21
gctctagacg atgattttgt gcagataggt 30
<210>22
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>22
gctctagaga acaagcccaa ccccaacctc 30
<210>23
<211>34
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>23
ataagcggcc gcgccgtctt ccttccagat gttg 34
<210>24
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>24
atgttctaca tgactggaca gga 23
<210>25
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>25
ctactttttc cctgcaatgt cga 23
<210>26
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>26
cccaagcttg ctggaaagct ctgggtgcca 30
<210>27
<211>29
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>27
gctctagagg tggaaccgcc gaagtgaga 29
<210>28
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>28
gctctagagt ggacgggctc tacgcggtcg 30
<210>29
<211>33
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>29
ataagcggcc gccgtcccgc tcgatgaact cgg 33
<210>30
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>30
atgacctcag acatcaaggt gttcg 25
<210>31
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>31
cgaacacctt gatgtctgag gtcat 25
<210>32
<211>19
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>32
gctcgtgtcg tgagatgtt 19
<210>33
<211>19
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>33
tgtagcccag gtcataagg 19
<210>34
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>34
accaaagtcg tggcggagaa at 22
<210>35
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>35
gatgttcttg ttgccgacca gc 22
<210>36
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>36
tcattgcccg gttgtctgtt gg 22
<210>37
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>37
cgatctgacg agcgagttct tcca 24
<210>38
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>38
ggattcccca agggtgtcat 20
<210>39
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>39
catccaggtg gccgactgcg 20
<210>40
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>40
gccgttctgc tcaacatgga cg 22
<210>41
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>41
gttcttggcg atctgctgtg cg 22
<210>42
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>42
aggaagcggt caacaagtac aac 23
<210>43
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>43
gtcttctcca gcgcatattg agtg 24
<210>44
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>44
acctatgaca cggagatcat c 21
<210>45
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>45
tcaacaacat tcgcgcatcc 20
<210>46
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>46
ttctacatcc acttcggtct gc 22
<210>47
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>47
cttgtagccg ctgtagttgt tg 22
<210>48
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>48
gcctggacgc cgactttctg t 21
<210>49
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>49
tagcacaaga ccacccgacc g 21
<210>50
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>50
ccgattacta ccccgagacc cc 22
<210>51
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>51
ggagcggacg ccgaccttga tg 22
<210>52
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>52
gcctgcccac catcatcaag cg 22
<210>53
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>53
cagttccgtc agtgcggtgt cg 22
<210>54
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>54
tgctggatga ggcgtggtgg tt 22
<210>55
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>55
ttgatgaatc gcctgccctc gc 22
Claims (1)
1. A method for producing 9-OHAD-highly productive mycobacteria comprising the steps of:
RNA extraction and RT-qPCR analysis
RNA was isolated from mycobacterial sterol transformation media using RNAprep pure cell/bacteria kit (TIANGEN), total RNA from different samples was concentrated in 30. mu. L RNase-free water according to kit instructions, RNA quality was verified using NanoDrop (NanoDrop 2000, Thermo) and 1% (w/v) agarose gel electrophoresis;
reverse transcribing 1. mu.g total RNA using the FastQuant cDNA kit (TIANGEN), pretreating the total RNA sample with DnaseI according to the kit instructions, 2. mu. L5 × g DNA buffer, 1. mu.g total RNA, adjusted to 10. mu. L with ddH2O, incubating at 42 ℃ for 3min, then immediately cooling the ice, then preparing a reverse transcription reaction mixture, 2. mu. L10 × Fast RT buffer, 1. mu. L RTEnzyma Mix, 2. mu. L FQ-RT primer MIX, 1. mu.g total RNA, adjusted to 20. mu. L with ddH2O, incubating at 42 ℃ for 15min, then incubating at 95 ℃ for 3min, then immediately cooling on ice, -20 ℃ preservation, -diluting the mixture 10-fold before quantitation in NanoDrop;
gene-specific qRT-PCR primers were designed and qRT-PCR was performed in cfx96(BioRad) using the SuperReal PreMix Plus kit (SYBR Green) (Tiangen), 2. mu. L of the above cDNA samples were mixed with 0.6. mu. L + 0.6. mu. L specific oligonucleotide, 10. mu. L2 × SuperReal PreMix Plus and 6.8. mu. L RNase-free ddH2O is mixed completely in a 20 μ L reaction mixture, RT-qPCR reaction is carried out for 15 minutes of pre-denaturation at 95 ℃ for 10 seconds for 40 cycles, at 60 ℃ for 20 seconds, at 72 ℃ for 20 seconds, followed by a melting curve phase at 55 ℃ to 95 ℃, control is a strain grown in a glycerol carbon source, test is a strain grown in a phytosterol carbon source, each sample is analyzed in triplicate, relative expression levels are calculated using the 2- Δ Δ CT method with the amplicon of the 16SrRNA gene as an internal control;
construction of (two) knock-out kstd Strain
Constructing a targeted gene deletion mutant of M.mycobacterium MS136, cloning first two fragments of upstream sequences 1112bp or 1361bp, downstream sequences 1057bp or 1293bp, tdks 3-down/-r, in order to delete kstd1 or kstd3, respectively, by primers kstd1-up-f/kstd3-up-r or kstd1-down-, then ligating the fragments to p 5bp or 2656 by XbaI enzyme, subsequently digesting the 2175bp or 2656bp fragment with HindIII/NotI, then cloning into plasmid p2NI L, finally inserting a PacI site of p2 using a PacI single digested selection marker cassette from pGoI 19 to generate homologous recombinant plasmids 1 or tdksel-tdpdpdpdp 3, after treatment with alkali, inserting the PacI site of the PacI gene into the PacI site of p2, as described above, after successful gene deletion of the original plasmid transfected cells from Gordks 3, or after deletion of the original plasmid 1bp, deletion of the mutant by PCR, finally deleting the mutant from the mutant with primers kstd 1bp 3-9-99, the sequence of the mutant, which was confirmed by electroporation, deletion of the mutant by PCR, using primers kstd1, or the primer kstd 369-19 bp, or the primer, the sequence of the deletion of the mutant after deletion of the mutant, which was determined by PCR, which was found to find the deletion of the original plasmid 3bp, or after deletion of the deletion mutant was found by PCR;
(III) construction of sterol metabolism-related Gene expression vector
Cloning of the gene 3 β -Hsd from the genome of MS136 using Hsd-pf & pr, BamHI-HindIII and ligating it to the plasmid pMV261 at the BamHI-HindIII site, introducing the plasmids pMV261 and pMV261-Hsd into MS136 to obtain MS136 and MS136-H, respectively, using 5-reductase-pf & pr, cyp125-pf & pr, fade 19-pf & pr, fadA5-pf & pr, kshA-pf & pr and kshB-pf & 829, cloning of the gene 5 α -4std, cyp125, fade 19, fadA5, hA and kshB from the genome of MS136, constructing the plasmid containing the genes HindIII + XbXksH + XksH, XksH & BamHI + XshIXksH & gt, XshIK & gt, XshIfSfS 136-AB 136-F, MS136-AB 136-S and MS136 gf-AB, respectively, using Hsd-pfIXshIJVdV 261-9, XshIJVdXshIJV, XshIJVdXshIJK & dSfI + XshIfI & dXhA & dSfI, plasmid, BamHI & dXshIfXshIfXshIfXshIfXshIfI & dXshIfI & dXpr829 & dXshIfI & dXshIfS, BamHI & d;
(IV) Mycobacterium electrotransformation
Treating an electric rotating cup (2mm), namely spraying 75% alcohol on the electric rotating cup, drying the electric rotating cup under ultraviolet light on a superclean bench, putting the electric rotating cup into an ice box for ice bath for 10min, putting a mycobacteria sensitive state tube on the ice box ice, standing the plasmid on the ice for 10min, adsorbing the competence added with the plasmid into the electric rotating cup, setting an electric rotating instrument parameter voltage 1800V, putting the electric rotating cup into an electric rotating instrument groove, performing electric rotation for 2 times, performing electric rotation, then performing ice bath for 3min, adding a seed culture medium of 800u L into the superclean bench, recovering for 2-3h in a 170r shaking table, centrifuging for 5min at 4000rpm, discarding supernatant, leaving about 100u L, resuspending the cells, sucking the cells onto a solid culture medium plate containing corresponding antibiotics by a liquid transfer gun, uniformly coating the solid culture medium plate until the cells are dry, allowing the colonies to grow, and selecting the bacteria for verification after 5-7 days;
(V) sample extraction, detection and quantification
The product is treated by placing 500u L fermentation liquor in a centrifuge tube, centrifuging for 15min at 4000rpm, sucking supernatant with an injector, filtering with 0.22um water system membrane into a clean centrifuge tube for standby, sucking 10u L filtrate, adding into 990u L diluent, mixing well for subsequent analysis and detection, and storing the rest filtrate at-20 deg.C;
the detection of the product 9-OHAD is that the 9-OHAD has a characteristic absorption peak under 240nm ultraviolet wavelength, but the substrate phytosterol has no characteristic absorption, so the product is quantitatively analyzed by adopting a HP L C method determination standard curve, the chromatographic conditions comprise that a chromatographic column is C18(250mm × 4.6.6 mm), the detection wavelength is 240nm, the column temperature is 50 ℃, the flow rate is 1.0m L/min, the mobile phase comprises ethanol, water, glacial acetic acid (520:480:0.1), the diluent comprises acetonitrile, water (50:50), and the sample injection amount is 20u L;
the primer sequences are as follows:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010178401.1A CN111484964A (en) | 2020-03-14 | 2020-03-14 | High-yield 9-OHAD mycobacterium and construction method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010178401.1A CN111484964A (en) | 2020-03-14 | 2020-03-14 | High-yield 9-OHAD mycobacterium and construction method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111484964A true CN111484964A (en) | 2020-08-04 |
Family
ID=71813598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010178401.1A Pending CN111484964A (en) | 2020-03-14 | 2020-03-14 | High-yield 9-OHAD mycobacterium and construction method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111484964A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111454871A (en) * | 2020-03-03 | 2020-07-28 | 天津大学 | Recombinant mycobacterium with high androstenedione yield, construction method and application |
CN112094797A (en) * | 2020-11-05 | 2020-12-18 | 中国科学院天津工业生物技术研究所 | Genetically engineered bacterium and application thereof in preparation of 9 alpha, 22-dihydroxy-23, 24-bis-cholesta-4-en-3-one |
CN114717173A (en) * | 2022-03-21 | 2022-07-08 | 华东理工大学 | Genetic engineering strain for producing sterol side chain incomplete degradation product and construction method and application thereof |
CN115029368A (en) * | 2022-06-24 | 2022-09-09 | 中国科学院上海高等研究院 | Gene engineering bacterium for producing dideoxy alcohol and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104232722A (en) * | 2014-08-21 | 2014-12-24 | 宋浩雷 | Method for producing 9-alpha-hydroxyandrostenedione by microbial fermentation |
CN108587997A (en) * | 2018-05-11 | 2018-09-28 | 江南大学 | A method of producing 9-OH-AD using recombination Corynebacterium glutamicum resting cell |
CN108913643A (en) * | 2018-08-01 | 2018-11-30 | 天津科技大学 | A method of it improving mycobacteria regenerating coenzyme and androstenedione is promoted to produce simultaneously |
CN110791468A (en) * | 2019-10-14 | 2020-02-14 | 江南大学 | Construction method and application of mycobacterium genetic engineering bacteria |
-
2020
- 2020-03-14 CN CN202010178401.1A patent/CN111484964A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104232722A (en) * | 2014-08-21 | 2014-12-24 | 宋浩雷 | Method for producing 9-alpha-hydroxyandrostenedione by microbial fermentation |
CN108587997A (en) * | 2018-05-11 | 2018-09-28 | 江南大学 | A method of producing 9-OH-AD using recombination Corynebacterium glutamicum resting cell |
CN108913643A (en) * | 2018-08-01 | 2018-11-30 | 天津科技大学 | A method of it improving mycobacteria regenerating coenzyme and androstenedione is promoted to produce simultaneously |
CN110791468A (en) * | 2019-10-14 | 2020-02-14 | 江南大学 | Construction method and application of mycobacterium genetic engineering bacteria |
Non-Patent Citations (5)
Title |
---|
HUGUES OUELLET 等: "Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one", 《MOLECULAR MICROBIOLOGY》 * |
YUNQIU ZHAO 等: "Production of 5α-androstene-3,17-dione from phytosterols by co-expression of 5α-reductase and glucose-6-phosphate dehydrogenase in engineered Mycobacterium neoaurum", 《GREEN CHEMISTRY》 * |
李园园 等: "新金分枝杆菌3β -脱氢酶(3β -HSD)的多基因控制机制", 《沈阳药科大学学报》 * |
王向栋: "分枝杆菌高效生产9α羟基雄烯二酮的代谢工程改造", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
赵晓雅等: "3β-羟基类固醇脱氢酶基因的克隆表达及其性质研究", 《现代生物医学进展》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111454871A (en) * | 2020-03-03 | 2020-07-28 | 天津大学 | Recombinant mycobacterium with high androstenedione yield, construction method and application |
CN112094797A (en) * | 2020-11-05 | 2020-12-18 | 中国科学院天津工业生物技术研究所 | Genetically engineered bacterium and application thereof in preparation of 9 alpha, 22-dihydroxy-23, 24-bis-cholesta-4-en-3-one |
CN114717173A (en) * | 2022-03-21 | 2022-07-08 | 华东理工大学 | Genetic engineering strain for producing sterol side chain incomplete degradation product and construction method and application thereof |
CN114717173B (en) * | 2022-03-21 | 2023-10-10 | 华东理工大学 | Genetically engineered strain for producing sterol side chain incomplete degradation product, construction method and application thereof |
CN115029368A (en) * | 2022-06-24 | 2022-09-09 | 中国科学院上海高等研究院 | Gene engineering bacterium for producing dideoxy alcohol and application thereof |
CN115029368B (en) * | 2022-06-24 | 2023-10-31 | 中国科学院上海高等研究院 | Genetically engineered bacterium for producing bisnoralcohol and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111484964A (en) | High-yield 9-OHAD mycobacterium and construction method thereof | |
EP1680504B1 (en) | Optimised micro-organism strains for nadph-consuming biosynthetic pathways | |
US20040267001A1 (en) | Genes encoding baeyer-villiger monooxygenases | |
CN110358692B (en) | Recombinant yeast strain for producing nervonic acid and application thereof | |
JP2021506247A (en) | Microorganisms and methods for the biological production of ethylene glycol | |
CN107002028A (en) | It is presented by the recombinant microorganism of the flux of the increase in fermentation path | |
Luo et al. | Differential expression of methanogenesis genes of Methanothermobacter thermoautotrophicus (formerly Methanobacterium thermoautotrophicum) in pure culture and in cocultures with fatty acid-oxidizing syntrophs | |
CN112094797B (en) | Genetically engineered bacterium and application thereof in preparation of 9 alpha, 22-dihydroxy-23, 24-bis-cholesta-4-en-3-one | |
Dickert et al. | Molecular characterization of phenyllactate dehydratase and its initiator from Clostridium sporogenes | |
CN112126610A (en) | Engineering bacterium for producing hydroxytyrosol | |
Chistoserdova et al. | Molecular characterization of a chromosomal region involved in the oxidation of acetyl-CoA to glyoxylate in the isocitrate-lyase-negative methylotroph Methylobacterium extorquens AM1 | |
CN115927029A (en) | Recombinant saccharomyces cerevisiae for producing cannabigerol acid and construction method and application thereof | |
Ma et al. | Promoting photo-fermentative hydrogen production performance by substituting the rnf promoter in Rhodobacter capsulatus | |
Sun et al. | Enhancing production of 9α-hydroxy-androst-4-ene-3, 17-dione (9-OHAD) from phytosterols by metabolic pathway engineering of mycobacteria | |
Zhang et al. | Coexpression of VHb and MceG genes in Mycobacterium sp. strain LZ2 enhances androstenone production via immobilized repeated batch fermentation | |
Perli et al. | Engineering heterologous molybdenum-cofactor-biosynthesis and nitrate-assimilation pathways enables nitrate utilization by Saccharomyces cerevisiae | |
CN112029701B (en) | Genetically engineered bacterium and application thereof in preparation of 22-hydroxy-23, 24-bis-cholesta-4-en-3-one | |
CN113046283A (en) | Engineering strain for producing adipic acid by reducing TCA (trichloroacetic acid) and construction method thereof | |
JP4668176B2 (en) | Triterpene hydroxylase | |
WO2013191349A1 (en) | Thermococcus onnurineus na1 mutant strain with increased hydrogen productivity, and method for producing hydrogen using same | |
Goomeshi Nobary et al. | A comparison of the clavam biosynthetic gene clusters in Streptomyces antibioticus Tü1718 and Streptomyces clavuligerus | |
Olson et al. | The involvement of hybrid cluster protein 4, HCP4, in anaerobic metabolism in Chlamydomonas reinhardtii | |
CN114990043A (en) | Engineering bacterium for metabolizing lysine and construction method and application thereof | |
EP3913063A1 (en) | Non-naturally occurring microorganism for the biosynthetic production of baicalein | |
CN109609522B (en) | Macleaya cordata dihydrobenzophenanthridine oxidase gene optimization sequence and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200804 |